<DOC>
	<DOCNO>NCT02051088</DOCNO>
	<brief_summary>Peripheral arterial disease ( PAD ) cause reduced blood flow low limb ( ) due stenosis occlusion supply artery . Symptoms PAD range ischemic rest pain and/or ischemic ulcers/gangrene ( critical limb ischemia ) , put extremity risk amputation , exercise-induced pain ( intermittent claudication ) , limit patient daily activity . Invasive treatment often indicate prevent amputation alleviate symptom . More two third procedure presently perform endovascular technique ( i.e . percutaneous transluminal angioplasty , PTA without stent implantation ) . In coronary artery disease , stent elute anti-proliferative drug ( drug elute stent , DES ) reduce restenosis improve clinical result majority patient . Drug elute balloon ( DEB ) promise alternative , still little evidence DES DEB technology improve clinical outcome PAD . However , promise result utilize new technology PAD report study . In trial , test hypothesis drug eluting ( DE ) technology superior conventional endovascular treatment ( no-DE ) term important clinical outcome , apply infrainguinal ( femoropopliteal and/or infrapopliteal ) obstructive vascular lesion . The trial consist 2 separate parallel study , SWEDEPAD 1 SWEDEPAD 2 , define severity peripheral arterial disease . Patients critical limb ischemia allocate SWEDEPAD 1 patient intermittent claudication allocate SWEDEPAD 2 .</brief_summary>
	<brief_title>Swedish Drug-elution Trial Peripheral Arterial Disease</brief_title>
	<detailed_description />
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<criteria>All adult &gt; 18 year old willing randomize Symptomatic PAD ( critical limb ischemia intermittent claudication ) cause &gt; 50 % stenosis occlusion infrainguinal artery eligible endovascular treatment accord establish indication Acute thromboembolic disease leg Infrainguinal aneurysmal disease Previous participation study randomise interventional study infrainguinal lesion Patients without Swedish personal identification number</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Critical limb ischemia</keyword>
	<keyword>Intermittent claudication</keyword>
	<keyword>endovascular treatment</keyword>
	<keyword>drug-elution</keyword>
</DOC>